June 24–26, 2027, Rome, Italy

Scientific Program · Heart Congress 2027

Heart Congress 2027 — Scientific Program

Day-by-day session and presentation schedule

The full Heart Congress 2027 scientific program across 3 days — keynotes, oral presentations, and posters. Talks are ordered by program prominence within each day.

Day 1

Day 1

  1. Keynote · In-Person

    Surgical options for aortic valve preservation

    John R Doty · Intermountain Medical Center, United States

    Refinements in cardiac surgical techniques can now offer many patients preservation of their native aortic valve rather than replacement with biologic or mechanical prostheses. These operations range from isolated…

  2. Keynote · In-Person

    Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks

    Sergey Suchkov · N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation

    Understanding personalized & precision cardiology (PPC) focuses on customizing medical interventions based on an individual’s unique genetic profile, biomarkers, targets and personal health data. Unlike conventional…

  3. Oral · In-Person

    Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice

    Sergey Suchkov · N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation

    Catalytic Abs (catAbs) are multivalent immunoglobulins (Igs) with a capacity to hydrolyze the antigenic (Ag) substrate. In this sense, proteolytic Abs (Ab-proteases) represent Abs to provide proteolytic effects. Abs…

  4. Oral · In-Person

    Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: Supporting evidence from cellular and animal models

    Bijoy Krishna Banik · National Institute of Pharmaceutical Education and Research Guwahati, India

    Introduction: Doxorubicin (DOX) is a broadly used anthracycline anticancer drug, but its therapeutic application is limited by cumulative, dose?dependent cardiotoxicity that may culminate in heart failure. Oxidative…

  5. Oral · In-Person

    Investigating the effect of a period of aerobic exercise on inflammatory and anti-inflammatory factors in atherosclerosis

    Mahdi Ghasemiartiyan · Independent Researcher, Iran (Islamic Republic of)

    An imbalance in the Th1/Th2 immune response, specifically a shift towards Th1 dominance, is associated with increased risk factors for heart disease. This imbalance can be seen in conditions like coronary artery disease…

  6. Poster · In-Person

    Comparison between self-reported therapeutic adherence and biomarkers in patients with heart failure

    Yoana Tenneth Mancilla Sandoval · Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico

    Background In Mexico, 135,748 people died from heart disease in 2025; one of the causes is low treatmen adherence, is assessed through self-reporting, where adherence is overestimated, limiting the effectiveness of the…

  7. Poster · In-Person

    Gender differences in therapeutic adherence, quality of life and presence of informal caregiver in patients with heart failure

    Fatima Michelle Villa Jimenez · Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico

    Background: Gender differences in patients with cardiovascular diseases have been little explored; pioneering studies suggest a differential impact on variables such as quality of life. In the Mexican context, it has…

  8. Poster · In-Person

    Cardiac Autonomic Neuropathy (CAN) in diabetics

    Hachichi Chaouki · Hospital Universitaire de Ouargla, Algeria

    Introduction: Cardiac autonomic neuropathy (CAN) is a common condition, the prevalence of which is underestimated in diabetic patients. Cardiovascular dysautonomia in diabetic patients has major complications, notably…

  9. Poster · In-Person

    Troponin ultra and myocardial infarction: Influence of age

    Hachichi Chaouki · Hospital Universitaire de Ouargla, Algeria

    Introduction: Cardiac troponins (cTn) play a key role in detecting myocardial necrosis in individuals suspected of having coronary syndrome (ACS). Newer, so-called ultra-sensitive or hypersensitive cTn assays…

  10. Poster · In-Person

    Systolic blood pressure index in elderly diabetics

    Hachichi Chaouki · Hospital Universitaire de Ouargla, Algeria

    Introduction: The risk of developing peripheral artery disease (PAD) increases significantly in diabetic patients, who are also more exposed to ischemic events than the general population. This risk is independent of…

Day 2

Day 2

  1. Keynote · Virtual

    Doppler ultrasound measurement of central artery elasticity: A new natural-frequency framework for cardiovascular risk assessment

    Trevor Tucker · Dynamic Vascular Resolution Inc., Canada

    Background: Arterial stiffness is a recognized biomarker of cardiovascular disease, traditionally quantified using carotid–femoral pulse wave velocity (cfPWV). Although cfPWV is the clinical gold standard, it is a…

  2. Keynote · Virtual

    Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic

    Agustin Joison · Cordoba Catholic University, Argentina

    Introduction: Globally, ischemic heart disease has become one of the leading causes of disability-adjusted life years (DALYs), ranking first among adults over the age of 50. Residual risk can be classified into three…

  3. Keynote · Virtual

    Assessment of a metabolic map 3.0 (MM3.0) in association with GLP-1 analogue in peri and menopause overweight

    Antonio Claudio Goulart Duarte · Federal University of Rio de Janeiro, Brazil

    MM3.0 helps to understand the true clinical evolution and the best strategy for the use of GLP-1 analogue. Perimenopause is the gradual transitional period preceding menopause, during which the ovaries progressively…

  4. Keynote · Virtual

    Antidiabetic agents – From treating diabetes to providing positive cardiovascular outcome

    Syed Raza · Awali Hospital, Bahrain

    Diabetes is a growing problem globally despite all advances in its management strategy. In the last decade particularly there has been a plethora of newer anti diabetic medications that have been introduced in the…

  5. Oral · Virtual

    Development and preclinical evaluation of advanced bio-textile architectures for targeted endovascular cardiovascular implants

    Narayanan Gokarneshan · SSM College of Engineering, India

    Due to a growing population suffering from ischemic heart disease, designing durable vascular prostheses remains a crucial hurdle in surgical and interventional cardiology. Conventional synthetic polymer grafts often…

  6. Oral · Virtual

    Magnetite Nanoparticles (MCS-B) as a basis for antibacterial action: Mechanisms and cinical perspectives

    Andrey Belousov · Laboratory of Applied Nanotechnology of Belousov and Kharkiv National Medical University, Ukraine

    Background : Today the world’s attention is locked on the problem of bacterial resistant to antibiotics – one of the most serious threats to humanity. About 5.000 patients a year in the UK died from bloodstream…

  7. Oral · Virtual

    DCA is optimal by TRI ??

    Takuma Tsuda · Nagoya Ekisaikai Hospital, Japan

    Background: DCA catheter (Atherocut; Nipro, Japan) usually need 8Fr guiding catheter because of its contrast effect however it is compatible for 7Fr guiding catheter. The aim of this study is to assess the clinical…

  8. Oral · Virtual

    Improving treatment adherence to antihypertensive therapy

    Mariia Aleksandrovna Shikina · FSBEI HE "Russian University of Medicine" of the Ministry of Health of the Russian Federation, Russian Federation

    Effective management of arterial hypertension depends not only on the efficacy of prescribed medications but also on patients’ adherence to treatment. Sustained adherence to antihypertensive therapy is essential for…

  9. Poster · Virtual

    The neuro-cardiac axis: Cellular and systemic consequences of acute stress in Takotsubo syndrome: A narrative review of stress-induced cardiomyopathy

    Parinaz Mohammadi · Islamic Azad University, Iran (Islamic Republic of)

    Takotsubo syndrome (TTS), often called "broken heart syndrome," is an acute and usually reversible form of left ventricular dysfunction that mimics acute coronary syndrome but is not explained by an obstructive coronary…

Day 3

Day 3

Being finalized

Talks for this day are added here as they are confirmed.

Present your research at Heart Congress 2027

Abstract submissions for the 2027 program are open · June 24–26, 2027 · NH Villa Carpegna, Rome.

Submit Abstract →

Join the Heart Congress 2027 delegation

Rome · June 24–26, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.

Chat with us